Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA03020087 Leukotriene B3 5S,12R-dihydroxy-6Z,8E,10E-eicosatrienoic acid FA 20:3;O2 C20H34O4 338.245710
LMFA03020087 Leukotriene B3 5S,12R-dihydroxy-6Z,8E,10E-eicosatrienoic acid FA 20:3;O2 C20H34O4 338.245710
LMFA03010221 tetranor-PGDM 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010221 tetranor-PGDM 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010221 tetranor-PGDM 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03040012 Lipoxin A5 5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid FA 20:5;O3 C20H30O5 350.209325
LMFA03040012 Lipoxin A5 5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid FA 20:5;O3 C20H30O5 350.209325
LMFA03010089 2,3-dinor, 6-keto-PGF1alpha 6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid FA 18:3;O4 C18H30O6 342.204240
LMFA03010089 2,3-dinor, 6-keto-PGF1alpha 6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid FA 18:3;O4 C18H30O6 342.204240
LMFA03010089 2,3-dinor, 6-keto-PGF1alpha 6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid FA 18:3;O4 C18H30O6 342.204240
LMFA01060223 10-oxo-11E-octadecenoic acid 10-oxo-11E-octadecenoic acid FA 18:2;O C18H32O3 296.235145
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010243 Tetranor-PGAM 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA03010244 PGDM 9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid FA 16:4;O5 C16H24O7 328.152205
LMFA02000419 9(Z),15(Z)-13-HODE 13-hydroxyoctadeca-9Z,15Z-dienoic acid FA 18:2;O C18H32O3 296.235145
LMFA02000419 9(Z),15(Z)-13-HODE 13-hydroxyoctadeca-9Z,15Z-dienoic acid FA 18:2;O C18H32O3 296.235145
LMFA02000420 9(Z),15(Z)-13-oxo-ODE 13-oxo-octadeca-9Z,15Z-dienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000420 9(Z),15(Z)-13-oxo-ODE 13-oxo-octadeca-9Z,15Z-dienoic acid FA 18:3;O C18H30O3 294.219495
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010245 13,14-dihydro-15-keto-tetranor Prostaglandin D2 9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010246 13,14-dihydro-15-keto-tetranor Prostaglandin E2 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid FA 16:3;O3 C16H26O5 298.178025
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03010247 tetranor-PGJM 11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid FA 16:5;O4 C16H22O6 310.141640
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224975
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224975
LMFA03110352 5-F3t-IsoP (E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid FA 20:4;O3 C20H32O5 352.224975
LMFA01170166 Octadeca-6Z,9Z-dienedioic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000421 9(Z)-13-HOME 13-Hydroxy-cis-9-octadecenoic acid FA 18:1;O C18H34O3 298.250795
LMFA02000421 9(Z)-13-HOME 13-Hydroxy-cis-9-octadecenoic acid FA 18:1;O C18H34O3 298.250795
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000423 6(Z),9(Z),13(E)-12-HOTrE 12-hydroxyoctadeca-6Z,9Z,13E-trienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000423 6(Z),9(Z),13(E)-12-HOTrE 12-hydroxyoctadeca-6Z,9Z,13E-trienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000424 6(Z),9(Z)-13-HODE 13-hydroxyoctadeca-6Z,9Z-dienoic acid FA 18:2;O C18H32O3 296.235145
LMFA02000424 6(Z),9(Z)-13-HODE 13-hydroxyoctadeca-6Z,9Z-dienoic acid FA 18:2;O C18H32O3 296.235145
LMFA02000425 6(Z),9(Z)-13-oxo-ODE 13-oxooctadeca-6Z,9Z-dienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000425 6(Z),9(Z)-13-oxo-ODE 13-oxooctadeca-6Z,9Z-dienoic acid FA 18:3;O C18H30O3 294.219495
LMFA02000426 6(Z)-10,13-DiHOME 10,13-dihydroxyoctadec-6Z-enoic acid FA 18:1;O2 C18H34O4 314.245710
LMFA02000426 6(Z)-10,13-DiHOME 10,13-dihydroxyoctadec-6Z-enoic acid FA 18:1;O2 C18H34O4 314.245710
LMFA02000427 6(Z)-10-HOME 10-hydroxyoctadec-6Z-enoic acid FA 18:1;O C18H34O3 298.250795
LMFA02000427 6(Z)-10-HOME 10-hydroxyoctadec-6Z-enoic acid FA 18:1;O C18H34O3 298.250795
LMFA02000428 6(Z)-10-oxo-HOME 10-oxooctadec-6Z-enoic acid FA 18:2;O C18H32O3 296.235145